Billionaire Hedge Fund Manager Michael Platt Invests in UK Biotech Firm Engitix
UK-based biotechnology company Engitix Ltd. has raised a further $25 million from billionaire Michael Platt to help develop its therapies…
UK-based biotechnology company Engitix Ltd. has raised a further $25 million from billionaire Michael Platt to help develop its therapies…
Two employees in pharmaceutical industry wearing protective gloves, mask, cap and white suit seen standing by the machine that is…
TheraVectys SA is considering an initial public offering in Hong Kong, according to people familiar with the matter, a rare…
C4 Therapeutics Inc. (NASDAQ:CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17,…
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab. www.marketwatch.com #biotech #stocks…
Boston-based Eventide Asset Management sold 114,922 shares of Mirum Pharmaceuticals during the third quarter. Despite the sale, the overall value…
Kentucky-based Aristides Capital fully exited its position in the iShares Biotechnology ETF (NASDAQ:IBB), reducing its portfolio by approximately $3.60 million,…
Top 10 Creations (All ETFs) Ticker Name Net Flows ($, mm) AUM ($, mm) AUM % Change MDY SPDR S&P…
Every year, TechCrunch’s Startup Battlefield pitch contest draws thousands of applicants. We whittle those applications down to the top 200…
If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of…